Patsy Newitt

Gastroenterology leaders faced an increasingly complex landscape in 2024, with closures, legal controversies and cyberattacks shaping the specialty’s future. 

Here are five major moves in the anesthesia industry that have recently gained traction: 

Here are five recent private equity deals, finalized or rumored, that ASCs are eyeing:

From pay cuts to workforce evolutions, 2024 was a tumultuous year for physicians. 

Walgreens Boots Alliance is reportedly considering selling itself to private equity firm Sycamore Partners and becoming private,  The Wall Street Journal reported Dec. 10. 

Gastroenterology billing is inherently complex and demands a strategic approach, especially as many industry leaders report that gastroenterology is disproportionately impacted by pay cuts and restrictive payer practices.

Becker’s has reported on more than five ASC closures so far in 2024. 

Oakland, Calif.-based Kaiser Permanente, a major employer of physicians, has inked major deals in 2024, expanding its reach in several states. 

Here are 19 anesthesiologists who have made Becker's headlines in the last month:

The American Society of Anesthesiologists and the American Association of Nurse Anesthesiology have both issued responses to Anthem Blue Cross Blue Shield's recent reversal of a controversial anesthesia policy.